Table 7.
Clinical stage II and duration.
| 1–12 months | 1–5 years | 5–10 years | >10 years | |
|---|---|---|---|---|
| Type I | 0 | 0 | 0 | 0 |
| Type II | 0 | 2 (2.12%) | 0 | 0 |
| Type III | 0 | 2 (2.12%) | 2 (2.12%) | 2 (2.12%) |
| Type IV | 2 (2.12%) | 22 (23.4%) | 0 | 0 |
| Type V | 8 (8.5%) | 24 (25.53%) | 8 (8.5%) | 2 (2.12%) |
| Combined | 0 | 8 (8.5%) | 10 (10.6%) | 2 (2.12%) |
χ 2 = 30.692; p < 0.001 VHS.